Weight Loss Drugs - Search News

7 facts about this weight loss drugs that actually work

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know about these game-changing medications.

NOLA.com · 1d

Can weight loss drugs curb alcohol addictions? New research looks at the possibility.

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

Medscape · 1d

New Weight Loss Drugs May Fight Obesity-Related Cancer, Too

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Restaurant Business · 10h

How weight-loss drugs will impact restaurants

The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic

New York Post on MSN · 9d

Ozempic 3.0? This drug causes the greatest weight loss — by far

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.

Reuters on MSN · 2d

Lilly sues two medical spas over copycat weight-loss drugs

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound. The new lawsuits name Thrive Health and Wellness LLC and Valhalla Vitality LLC.

MarketWatch · 1d

Eli Lilly’s stock falls as weight-loss drug sales disappoint

Shares of Eli Lilly and Co. slipped 0.4% in premarket trading Tuesday, after the drug maker provided a disappointing fourth-quarter revenue outlook, citing slower-than-expected growth in sales of its weight-loss drugs.

Wall Street Journal · 1d

Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs

Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.

Reuters on MSN · 1d

Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump

Eli Lilly forecast sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street estimates in the fourth quarter, sending the drugmaker's shares down more than 8% on Tuesday.

Barron's on MSN · 18h

Eli Lilly Stumbled But Weight-Loss Drugs Will Continue to Fuel Markets. Here’s Why and 5 Other Things to Know Today.

SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start your day.

Wall Street Journal · 1d

Eli Lilly Stock Falls on Slower Sales Growth of Anti-Obesity Drug

Eli Lilly shares fell after the drugmaker warned that sales of its hot diabetes and anti-obesity drugs are growing more slowly than expected. Lilly now expects fourth-quarter sales of $3.5 billion for diabetes drug Mounjaro and $1.

'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

1don MSN

Sheryl Lee Ralph Reveals Why She Slimmed Down Without Weight-Loss Drugs: 'If That Would've Worked, I Would Have' (Exclusive)

Abbott Elementary' star Sheryl Lee Ralph gets candid about focusing on her health and overhauling her lifestyle without ...

Maker of weight-loss drugs to ask Trump to pause price negotiations: Report

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Live 5 News6d

Understanding pros and cons of medical weight loss drugs: What you need to know

CHARLESTON, S.C. (WCSC) - As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded ...

The Next Web5d

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss drugs, Ozempic and Wegovy. The company promises to offer less invasive ...